Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers

Experimental Dermatology

Volumn 25, Issue 8, 2016, Pages 642-643

  Jabbari, Ali ^a   Nguyen, Nhan ^a   Cerise, Jane E ^a   Ulerio, Grace ^a   de Jong, Annemieke ^a   Clynes, Raphael ^a   Christiano, Angela M ^a   Mackay Wiggan, Julian ^a  

^a Columbia University ^*  (United States)

Author keywords

alopecia areata; biomarkers; JAK inhibitors; tofacitinib

Indexed keywords

CORTICOSTEROID; DITHRANOL; GAMMA INTERFERON INDUCIBLE PROTEIN 10; TOFACITINIB;

AA DISEASE ACTIVITY INDEX; ADULT; ALOPECIA AREATA; BLOOD CELL COUNT; CASE REPORT; CONTROLLED STUDY; EYEBROW; EYELASH; FEMALE; GENE EXPRESSION; HAIR GROWTH; HUMAN; HUMAN TISSUE; LETTER; PROTEIN BLOOD LEVEL; PUNCH BIOPSY; SCALP HAIR; SCORING SYSTEM; SKIN; SKIN BIOPSY;

EID: 84979574312     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.13060     Document Type: Letter

References (5)

1. Craiglow B G, King B A. J Invest Dermatol 2014: 134: 2988–2990.
2. Jabbari A, Dai Z, Xing L et al. EBioMedicine 2015: 2: 351–355.
3. Xing L, Dai Z, Jabbari A et al. Nat Med 2014: 20: 1043–1049.
4. Betz R C, Petukhova L, Ripke S et al. Nat Commun 2015: 6: 5966.
5. Jabbari A, Petukhova L, Cabral R M et al. Dermatol Clin 2013: 31: 109–117.